Alan Richard Bell is now serving in a new board position at Parnell Pharmaceuticals Holdings Ltd.
Jun 27, 2018
Board and Executive Moves
Former Managing Director & Owner at Parnell Laboratories (Aust) Pty Ltd.
In The News
Jun 27, 2018 - RelSci
Dec 11, 2014 - Kansas City Business Journal
Parnell Pharmaceuticals Holdings Ltd. is a veterinary pharmaceutical company, which engages in the development, manufacture, and commercializing animal health solutions. It operates through the following segments: Companion Animal, Production Animal-U.S., Production Animal-Rest of World, and Manufacturing Operations. The Companion Animal segment sells osteoarthritis suite of products Zydax, Glyde, and Tergive for canine, and equine species. The Production Animal-U.S. segment includes reproductive hormone portfolio across production animals. The Production Animal-Rest of World segment provides reproductive hormone products outside of the U.S. The Manufacturing Operations segment involves in sterile manufacturing and release of pharmaceutical products. The company was founded on June 25, 2009 and is headquartered in Sydney, Australia.
In The News
White Oak Healthcare Finance Supports Acquisition of Australian Based Parnell Pharmaceuticals by DW Healthcare
Mar 02, 2021 - Business Wire
Feb 01, 2021 - PR Newswire